Predictive value of β2-microglobulin (β2-m) levels in chronic lymphocytic leukemia since Binet A stages

Slični predmeti

• MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study
  od: Ennio Nano, i dr.
  Izdano: (2024-08-01)
• Predictive value of β2-microglobulin (β2-m) levels in chronic lymphocytic leukemia since Binet A stages
  od: Massimo Gentile, i dr.
  Izdano: (2009-06-01)
• Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
  od: Paola Monti, i dr.
  Izdano: (2020-10-01)
• Antitumor Effects of PRIMA-1 and PRIMA-1^Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
  od: Paola Menichini, i dr.
  Izdano: (2021-01-01)
• Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
  od: Fortunato Morabito, i dr.
  Izdano: (2021-08-01)